SD Biosensor에스디바이오센서
137310 · KOSPI · ₩137310 · 에스디바이오센서
₩6,340▼ ₩130 (2.01%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 46.8% | 45.8% | 48.9% | 19.2% | 47.5% | 53.6% |
| Operating margin | −8.8% | −11.4% | −7.8% | −37.8% | 39.1% | 46.6% |
| Net margin | −98.7% | −72.1% | −14.2% | −71.3% | 31.1% | 36.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +4.0% | +2.3% | +5.9% | −77.6% | +0.1% | — |
| Operating income growth | +20.1% | −49.7% | +78.2% | −121.6% | −15.9% | — |
| Net income growth | −42.4% | −420.4% | +79.0% | −151.3% | −14.4% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −30.8% | −19.5% | −3.4% | −16.2% | 35.5% | 48.6% |
| Return on assets | −23.8% | −14.4% | −2.6% | −13.3% | 29.0% | 35.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 20.6% | 38.8% | 32.6% | 33.8% | 10.7% | 36.4% |
| Net debt to equity | −1.9% | −5.1% | 4.1% | 1.3% | −63.5% | −38.6% |
| Current ratio | 651.0% | 264.4% | 531.5% | 300.8% | 847.6% | 330.6% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: SD Biosensor / 에스디바이오센서 / 137310 / KRX:137310
Source: KRX statistical information